Literature DB >> 24747950

Targeted shRNA screening identified critical roles of pleckstrin-2 in erythropoiesis.

Baobing Zhao1, Ganesan Keerthivasan1, Yang Mei1, Jing Yang1, James McElherne1, Piu Wong2, John G Doench3, Gang Feng4, David E Root3, Peng Ji5.   

Abstract

Differentiation of erythroblasts to mature red blood cells involves dynamic changes of the membrane and cytoskeleton networks that are not fully characterized. Using a mouse fetal liver erythroblast culture system and a targeted shRNA functional screening strategy, we identified a critical role of pleckstrin-2 in actin dynamics and protection of early stage terminal erythroblasts from oxidative damage. Knockdown of pleckstrin-2 in the early stage of terminal erythropoiesis disrupted the actin cytoskeleton and led to differentiation inhibition and apoptosis. This pro-survival and differentiation function of pleckstrin-2 was mediated through its interaction with cofilin, by preventing cofilin's mitochondrial entry when the intracellular level of reactive oxygen species was higher in the early stage of terminal erythropoiesis. Treatment of the cells with a scavenger of reactive oxygen species rescued cofilin's mitochondrial entry and differentiation inhibition induced by pleckstrin-2 knockdown. In contrast, pleckstrin-2 knockdown in late stage terminal erythroblasts had no effect on survival or differentiation but blocked enucleation due to disorganized actin cytoskeleton. Thus, our study identified a dual function of pleckstrin-2 in the early and late stages of terminal erythropoiesis through its regulations of actin dynamics and cofilin's mitochondrial localization, which reflects intracellular level of reactive oxygen species in different developmental stages. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24747950      PMCID: PMC4077076          DOI: 10.3324/haematol.2014.105809

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  48 in total

1.  Mitochondrial translocation of cofilin is an early step in apoptosis induction.

Authors:  Boon Tin Chua; Christiane Volbracht; Kuan Onn Tan; Rong Li; Victor C Yu; Peng Li
Journal:  Nat Cell Biol       Date:  2003-11-23       Impact factor: 28.824

2.  Signaling and cytoskeletal requirements in erythroblast enucleation.

Authors:  Diamantis G Konstantinidis; Suvarnamala Pushkaran; James F Johnson; Jose A Cancelas; Stefanos Manganaris; Chad E Harris; David A Williams; Yi Zheng; Theodosia A Kalfa
Journal:  Blood       Date:  2012-03-28       Impact factor: 22.113

3.  Tropomodulin3-null mice are embryonic lethal with anemia due to impaired erythroid terminal differentiation in the fetal liver.

Authors:  Zhenhua Sui; Roberta B Nowak; Andrea Bacconi; Nancy E Kim; Hui Liu; Jie Li; Amittha Wickrema; Xiu-li An; Velia M Fowler
Journal:  Blood       Date:  2013-10-24       Impact factor: 22.113

4.  Oxidant-induced apoptosis is mediated by oxidation of the actin-regulatory protein cofilin.

Authors:  Fábio Klamt; Stéphanie Zdanov; Rodney L Levine; Ashley Pariser; Yaqin Zhang; Baolin Zhang; Li-Rong Yu; Timothy D Veenstra; Emily Shacter
Journal:  Nat Cell Biol       Date:  2009-09-06       Impact factor: 28.824

Review 5.  Formation of mammalian erythrocytes: chromatin condensation and enucleation.

Authors:  Peng Ji; Maki Murata-Hori; Harvey F Lodish
Journal:  Trends Cell Biol       Date:  2011-05-17       Impact factor: 20.808

6.  Histone deacetylase 2 is required for chromatin condensation and subsequent enucleation of cultured mouse fetal erythroblasts.

Authors:  Peng Ji; Victor Yeh; Tzutzuy Ramirez; Maki Murata-Hori; Harvey F Lodish
Journal:  Haematologica       Date:  2010-09-07       Impact factor: 9.941

7.  A novel role for survivin in erythroblast enucleation.

Authors:  Ganesan Keerthivasan; Hui Liu; Jacob M Gump; Steven F Dowdy; Amittha Wickrema; John D Crispino
Journal:  Haematologica       Date:  2012-04-04       Impact factor: 9.941

Review 8.  ADF/cofilin: a functional node in cell biology.

Authors:  Barbara W Bernstein; James R Bamburg
Journal:  Trends Cell Biol       Date:  2010-02-03       Impact factor: 20.808

9.  Chromatin condensation in terminally differentiating mouse erythroblasts does not involve special architectural proteins but depends on histone deacetylation.

Authors:  Evgenya Y Popova; Sharon Wald Krauss; Sarah A Short; Gloria Lee; Jonathan Villalobos; Joan Etzell; Mark J Koury; Paul A Ney; Joel Anne Chasis; Sergei A Grigoryev
Journal:  Chromosome Res       Date:  2009-01-27       Impact factor: 5.239

10.  Erythroblast enucleation.

Authors:  Ganesan Keerthivasan; Amittha Wickrema; John D Crispino
Journal:  Stem Cells Int       Date:  2011-10-05       Impact factor: 5.443

View more
  15 in total

1.  KLF1-null neonates display hydrops fetalis and a deranged erythroid transcriptome.

Authors:  Graham W Magor; Michael R Tallack; Kevin R Gillinder; Charles C Bell; Naomi McCallum; Bronwyn Williams; Andrew C Perkins
Journal:  Blood       Date:  2015-02-27       Impact factor: 22.113

Review 2.  Chromatin condensation during terminal erythropoiesis.

Authors:  Baobing Zhao; Jing Yang; Peng Ji
Journal:  Nucleus       Date:  2016-08-31       Impact factor: 4.197

3.  Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms.

Authors:  Baobing Zhao; Yang Mei; Lan Cao; Jingxin Zhang; Ronen Sumagin; Jing Yang; Juehua Gao; Matthew J Schipma; Yanfeng Wang; Chelsea Thorsheim; Liang Zhao; Timothy Stalker; Brady Stein; Qiang Jeremy Wen; John D Crispino; Charles S Abrams; Peng Ji
Journal:  J Clin Invest       Date:  2017-11-20       Impact factor: 14.808

Review 4.  Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms.

Authors:  Alexandre Guy; Johanne Poisson; Chloe James
Journal:  Leukemia       Date:  2021-03-03       Impact factor: 11.528

5.  Erythropoietin-regulated oxidative stress negatively affects enucleation during terminal erythropoiesis.

Authors:  Baobing Zhao; Yang Mei; Jing Yang; Peng Ji
Journal:  Exp Hematol       Date:  2016-06-27       Impact factor: 3.084

Review 6.  Erythroid enucleation: a gateway into a "bloody" world.

Authors:  Vijay Menon; Saghi Ghaffari
Journal:  Exp Hematol       Date:  2021-01-10       Impact factor: 3.084

7.  Regulation of RNA polymerase II activity is essential for terminal erythroid maturation.

Authors:  Zachary C Murphy; Kristin Murphy; Jacquelyn Myers; Michael Getman; Tyler Couch; Vincent P Schulz; Kimberly Lezon-Geyda; Cal Palumbo; Hongxia Yan; Narla Mohandas; Patrick G Gallagher; Laurie A Steiner
Journal:  Blood       Date:  2021-11-04       Impact factor: 22.113

8.  The Promotion of Erythropoiesis via the Regulation of Reactive Oxygen Species by Lactic Acid.

Authors:  Shun-Tao Luo; Dong-Mei Zhang; Qing Qin; Lian Lu; Min Luo; Fu-Chun Guo; Hua-Shan Shi; Li Jiang; Bin Shao; Meng Li; Han-Shuo Yang; Yu-Quan Wei
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

9.  Anti-band 3 and anti-spectrin antibodies are increased in Plasmodium vivax infection and are associated with anemia.

Authors:  Luiza Carvalho Mourão; Rodrigo de Paula Baptista; Zélia Barbosa de Almeida; Priscila Grynberg; Maíra Mazzoni Pucci; Thiago Castro-Gomes; Cor Jesus Fernandes Fontes; Sumit Rathore; Yagya D Sharma; Rosiane A da Silva-Pereira; Marcelo Porto Bemquerer; Érika Martins Braga
Journal:  Sci Rep       Date:  2018-06-08       Impact factor: 4.379

10.  Peripheral Blood Transcriptomic Signatures of Fasting Glucose and Insulin Concentrations.

Authors:  Brian H Chen; Marie-France Hivert; Marjolein J Peters; Luke C Pilling; John D Hogan; Lisa M Pham; Lorna W Harries; Caroline S Fox; Stefania Bandinelli; Abbas Dehghan; Dena G Hernandez; Albert Hofman; Jaeyoung Hong; Roby Joehanes; Andrew D Johnson; Peter J Munson; Denis V Rybin; Andrew B Singleton; André G Uitterlinden; Saixia Ying; David Melzer; Daniel Levy; Joyce B J van Meurs; Luigi Ferrucci; Jose C Florez; Josée Dupuis; James B Meigs; Eric D Kolaczyk
Journal:  Diabetes       Date:  2016-09-13       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.